NCBI Taxonomy: 35619
Streptomyces griseoflavus (ncbi_taxid: 35619)
found 81 associated metabolites at species taxonomy rank level.
Ancestor: Streptomyces
Child Taxonomies: Streptomyces griseoflavus Tu4000, Streptomyces griseoflavus subsp. pyrindicus
Pyrrole-2-carboxylic acid
Pyrrole-2-carboxylic acid was synthesized over a century ago, but its history as a compound of biological origin is rather recent. It was first identified as a degradation product of sialic acids, then as a derivative of the oxidation of the D-hydroxyproline isomers by mammalian D-amino acid oxidase. The latter relationship results from the lability of the direct oxidation product, A-pyrroline-4-hydroxy-2-carboxylic acid, which loses water spontaneously to form the pyrrole. A similar reaction is catalyzed by the more specific allohydroxy-D-proline oxidase of Pseudomonas. In whole animal observations, pyrrole-2-carboxylate (PCA) was identified in rat or human urine after administration of the D-isomers of hydroxyproline, a finding ascribable to the action of D-amino acid oxidase. (PMID:4430715). Urinary excretion of N-(pyrrole-2-carboxyl) glycine has been reported in a 5-year-old affected with type II hyperprolinemia; The child has mild developmental delay, recurrent seizures of the grand mal type and EEG alterations. The urinary excretion of the conjugate is stressed, since it appears that only one previous report in the literature described this compound in the urine of two patients affected by this disturbance (PMID 2383933). Pyrrole-2-carboxylic acid was synthesized over a century ago, but its history as a compound of biological origin is rather recent. It was first identified as a degradation product of sialic acids, then as a derivative of the oxidation of the D-hydroxyproline isomers by mammalian D-amino acid oxidase. The latter relationship results from the lability of the direct oxidation product, A-pyrroline-4-hydroxy-2-carboxylic acid, which loses water spontaneously to form the pyrrole. A similar reaction is catalyzed by the more specific allohydroxy-D-proline oxidase of Pseudomonas. In whole animal observations, pyrrole-2-carboxylate (PCA) was identified in rat or human urine after administration of the D-isomers of hydroxyproline, a finding ascribable to the action of D-amino acid oxidase. (PMID: 4430715) KEIO_ID P112 Pyrrole-2-carboxylic acid is a natural alkaloid from the marine bacterium Pelomonas puraquae sp. Nov. Pyrrole-2-carboxylic acid is a natural alkaloid from the marine bacterium Pelomonas puraquae sp. Nov.
Bicozamycin
C12H18N2O7 (302.11139579999997)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals C784 - Protein Synthesis Inhibitor D004791 - Enzyme Inhibitors
Pyrrole 2-carboxylate
A pyrrolecarboxylic acid that is 1H-pyrrole substituted by a carboxy group at position 3. It has been isolated from Penicillium chrysogenum. A pyrrolecarboxylic acid that is 1H-pyrrole carrying a carboxy substituent at position 2. Pyrrole-2-carboxylic acid is a natural alkaloid from the marine bacterium Pelomonas puraquae sp. Nov. Pyrrole-2-carboxylic acid is a natural alkaloid from the marine bacterium Pelomonas puraquae sp. Nov.
Minalin
Pyrrole-2-carboxylic acid is a natural alkaloid from the marine bacterium Pelomonas puraquae sp. Nov. Pyrrole-2-carboxylic acid is a natural alkaloid from the marine bacterium Pelomonas puraquae sp. Nov.
2,4,10,14,17-pentahydroxy-7,7,12-trimethylpentacyclo[13.3.1.0⁵,¹⁸.0⁸,¹⁷.0¹¹,¹⁶]nonadeca-1(18),2,4,8,11(16),12,14-heptaene-6,19-dione
3,10,12,16-tetramethyl-14-methylidene-15,17-dioxo-18,20-dioxatetracyclo[11.5.2.0¹,⁶.0¹⁶,¹⁹]icos-4-ene-4-carboxylic acid
12-[3,4-dihydroxy-5-(1-hydroxyethyl)oxolan-2-yl]-5-ethenyl-15-hydroxy-3,17-dimethoxy-9-oxatetracyclo[8.8.0.0²,⁷.0¹¹,¹⁶]octadeca-1(10),2(7),3,5,11(16),12,14,17-octaen-8-one
2-{[2-({[4-benzyl-2,5,8,11,14,17,20,23,26,29,38,41,44,47,50,53,56,59,62-nonadecahydroxy-60-(c-hydroxycarbonimidoylmethyl)-39-(hydroxymethyl)-19-[(4-hydroxyphenyl)methyl]-25,28-diisopropyl-7,22-dimethyl-51-(2-methylpropyl)-45-(sec-butyl)-33,34,64,65-tetrathia-3,6,9,12,15,18,21,24,27,30,37,40,43,46,49,52,55,58,61-nonadecaazatricyclo[34.21.5.4¹³,⁵⁴]hexahexaconta-2,5,8,11,14,17,20,23,26,29,37,40,43,46,49,52,55,58,61-nonadecaen-31-yl](hydroxy)methylidene}amino)-1-hydroxy-3-phenylpropylidene]amino}-3-(1h-indol-3-yl)propanoic acid
C97H131N23O26S4 (2161.8518026)
(2e)-n-[(2s,3r,4r,5s,6r)-2-{[(2s,3r,4s,5r,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-6-[(2r)-2-[(2s,3s,4r,5s)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]-2-hydroxyethyl]-4,5-dihydroxyoxan-3-yl]-12-methyltridec-2-enimidic acid
(2e)-n-[(2s,3r,4r,5s,6s)-2-{[(2s,3r,4r,5r,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-6-[(2r)-2-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]-2-hydroxyethyl]-4,5-dihydroxyoxan-3-yl]-12-methyltridec-2-enimidic acid
(2e,10r)-n-[(2r,3r,4r,5r,6s)-2-{[(2s,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-6-[(2s)-2-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]-2-hydroxyethyl]-4,5-dihydroxyoxan-3-yl]-10-methyldodec-2-enimidic acid
n-(5-hydroxy-5-{8-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)carbamoyl]octa-1,3,5,7-tetraen-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl)deca-2,4,6,8-tetraenimidic acid
(1s,3s,6s,10r,12r,13r,16r,19r)-3,10,12,16-tetramethyl-14-methylidene-15,17-dioxo-18,20-dioxatetracyclo[11.5.2.0¹,⁶.0¹⁶,¹⁹]icos-4-ene-4-carboxylic acid
2,3-dihydroxypropyl 7-hydroxy-2-(4-hydroxy-6-methyl-2-oxo-5,6-dihydropyran-3-yl)-9h-pyrido[2,3-b]indole-4-carboxylate
(2e)-n-[(2r,3s,4s,5r,6s)-2-{[(2s,3s,4r,5s,6s)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-6-[(2s)-2-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]-2-hydroxyethyl]-4,5-dihydroxyoxan-3-yl]-10-methylundec-2-enimidic acid
5-ethenyl-15-hydroxy-3,17-dimethoxy-9-oxatetracyclo[8.8.0.0²,⁷.0¹¹,¹⁶]octadeca-1(10),2(7),3,5,11(16),12,14,17-octaen-8-one
3-(4-hydroxy-3-methoxyphenyl)-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)prop-2-enimidic acid
(2s)-n-[(3r,4r,7s,10r,13s,16s,20r,21as)-16-[(2s)-butan-2-yl]-5,8,11,14-tetrahydroxy-3-methyl-10-{[(1r,2r)-2-nitrocyclopropyl]methyl}-1,17-dioxo-7,13-bis[(1r)-1-phenylethyl]-20-[(1z)-prop-1-en-1-yl]-3h,4h,7h,10h,13h,16h,19h,20h,21h,21ah-pyrrolo[2,1-c]1-oxa-4,7,10,13,16-pentaazacyclononadecan-4-yl]-2-[(5-chloro-1-hydroxypyrrol-2-yl)formamido]-3-[(1r,2r)-2-nitrocyclopropyl]propanimidic acid
C55H69ClN10O14 (1128.4683003999999)
(2e,4e,6z,8e)-n-[(1s,5r)-5-hydroxy-5-[(1e,3e,5e,7e)-8-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)-c-hydroxycarbonimidoyl]octa-1,3,5,7-tetraen-1-yl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]deca-2,4,6,8-tetraenimidic acid
(2s)-2,3-dihydroxypropyl 7-hydroxy-2-(4-hydroxy-6-methyl-2-oxo-5,6-dihydropyran-3-yl)-9h-pyrido[2,3-b]indole-4-carboxylate
5-[(1e)-but-1-en-1-yl]-3-methyl-2h,3h,4h,6h,7h-cyclopenta[b]pyridine
(2e)-3-(4-hydroxy-3-methoxyphenyl)-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)prop-2-enimidic acid
(10s,17r)-2,4,10,14,17-pentahydroxy-7,7,12-trimethylpentacyclo[13.3.1.0⁵,¹⁸.0⁸,¹⁷.0¹¹,¹⁶]nonadeca-1(18),2,4,8,11(16),12,14-heptaene-6,19-dione
15-hydroxy-3,17-dimethoxy-5-methyl-12-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]-9-oxatetracyclo[8.8.0.0²,⁷.0¹¹,¹⁶]octadeca-1(10),2(7),3,5,11(16),12,14,17-octaen-8-one
(2e,4e,6z,8e)-n-[(1s,5s,6r)-5-hydroxy-5-[(1e,3e,5e,7e)-8-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)-c-hydroxycarbonimidoyl]octa-1,3,5,7-tetraen-1-yl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]deca-2,4,6,8-tetraenimidic acid
(2z,12r)-n-[(2s,3r,4r,5s,6s)-2-{[(2s,3r,4r,5s,6s)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-6-[(2r)-2-[(2s,3s,4r,5s)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]-2-hydroxyethyl]-4,5-dihydroxyoxan-3-yl]-12-methyltetradec-2-enimidic acid
(2e)-n-[(2r,3s,4s,5s,6r)-2-{[(2s,3s,4r,5s,6s)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-6-[(2r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]-2-hydroxyethyl]-4,5-dihydroxyoxan-3-yl]-10-methylundec-2-enimidic acid
(2e,10s)-n-[(2r,3r,4s,5r,6s)-2-{[(2s,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-6-[(2r)-2-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]-2-hydroxyethyl]-4,5-dihydroxyoxan-3-yl]-10-methyldodec-2-enimidic acid
(2e,12s)-n-[(2r,3s,4s,5r,6s)-2-{[(2r,3r,4r,5r,6s)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-6-[(2r)-2-[(2s,3s,4r,5s)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]-2-hydroxyethyl]-4,5-dihydroxyoxan-3-yl]-12-methyltetradec-2-enimidic acid
C38H64N4O16 (832.4317103999999)